Abnormal Serum Biochemical Results and Mitochondrial Damage of Lymphocytes in Patients with Schizophrenia and SARS-CoV-2 Infection: A Retrospective Study

References

• Li Q, Guan X, Wu P, et al. early transmission dynamics in Wuhan, China, of novel Coronavirus-infected pneumonia. N Engl J Med. 2020;382:1199–1207. doi:10.1056/NEJMoa2001316
   PubMed Web of Science ®Google Scholar
• Suzuki R, Yamasoba D, Kimura I, et al. Attenuated fusogenicity and pathogenicity of SARS-CoV-2 Omicron variant. Nature. 2022;603:700–705. doi:10.1038/s41586-022-04462-1
   PubMed Web of Science ®Google Scholar
• Gao SJ, Guo H, Luo G. Omicron variant (B.1.1.529) of SARS-CoV-2, a global urgent public health alert! J Med Virol. 2022;94:1255–1256. doi:10.1002/jmv.27491
   PubMed Web of Science ®Google Scholar
• Barlati S, Nibbio G, Vita A. Schizophrenia during the COVID-19 pandemic. Curr opin psych. 2021;34:203–210. doi:10.1097/YCO.0000000000000702
   PubMed Web of Science ®Google Scholar
• Wang Q, Xu R, Volkow ND. Increased risk of COVID-19 infection and mortality in people with mental disorders: analysis from electronic health records in the United States. World Psych. 2021;20:124–130. doi:10.1002/wps.20806
   PubMed Web of Science ®Google Scholar
• Charernboon T. Season of birth in patients with Schizophrenia in Thailand. Alpha Psychiatry. 2023;24:200–204. doi:10.5152/alphapsychiatry.2023.231259
   PubMedGoogle Scholar
• Velligan DI, Rao S. The epidemiology and global burden of Schizophrenia. J Clin Psychiatry. 2023;84. doi:10.4088/JCP.MS21078COM5
   Web of Science ®Google Scholar
• Cilia BJ, Eratne D, Wannan C, et al. Associations between structural brain changes and blood neurofilament light chain protein in treatment-resistant schizophrenia. medRxiv. 2024. doi:10.1101/2024.04.07.24305362
   PubMedGoogle Scholar
• Donmezler S, Iskender G, Fistikci N, et al. Exploring the ”Insight Paradox” in treatment-resistant schizophrenia: correlations between dimensions of insight and depressive symptoms in patients receiving clozapine. Alpha Psychiatry. 2023;24:102–107. doi:10.5152/alphapsychiatry.2023.221030
   PubMedGoogle Scholar
• Percudani M, Panariello A, Deste G, et al. Socio-demographic and clinical characteristics of SARS-CoV-2-positive psychiatric in-patients: a case-control study in the psychiatric wards of a great metropolitan hospital in Milan. Psychiatry Res. 2023;322:115042. doi:10.1016/j.psychres.2022.115042
   PubMed Web of Science ®Google Scholar
• Pourfridoni M, Askarpour H. COVID-19 and the increase in schizophrenia incidence in the future: a hypothesis and a serious warning. Health Sci Rep. 2023;6:e978. doi:10.1002/hsr2.978
   PubMedGoogle Scholar
• Severance EG, Dickerson FB, Viscidi RP, et al. Coronavirus immunoreactivity in individuals with a recent onset of psychotic symptoms. Schizophr Bull. 2011;37:101–107. doi:10.1093/schbul/sbp052
   PubMed Web of Science ®Google Scholar
• Kozloff N, Mulsant BH, Stergiopoulos V, et al. The COVID-19 global pandemic: Implications for people with schizophrenia and related disorders. Schizophr Bull. 2020;46:752–757. doi:10.1093/schbul/sbaa051
   PubMed Web of Science ®Google Scholar
• Cheng X, Huang X, Wu X, et al. Impact of the COVID-19 pandemic on lifestyle and mental state in patients with schizophrenia: a retrospective study. Medicine. 2023;102:e32830. doi:10.1097/MD.0000000000032830
   PubMed Web of Science ®Google Scholar
• Sanchez-Recalde A, Solano-Lopez J, Miguelena-Hycka J, et al. COVID-19 and cardiogenic shock. Different cardiovascular presentations with high mortality. Rev Esp Cardiol. 2020;73:669–672. doi:10.1016/j.rec.2020.04.012
   Web of Science ®Google Scholar
• Lim JH, Park SH, Jeon Y, et al. Fatal Outcomes of COVID-19 in patients with severe acute kidney injury. J Clin Med. 2020;9:1718. doi:10.3390/jcm9061718
   PubMed Web of Science ®Google Scholar
• Dong X, Sun L, Li Y. Prognostic value of lactate dehydrogenase for in-hospital mortality in severe and critically ill patients with COVID-19. Int J Med Sci. 2020;17:2225–2231. doi:10.7150/ijms.47604
   PubMed Web of Science ®Google Scholar
• Alfarouk KO, Alhoufie STS, Hifny A, et al. Of mitochondrion and COVID-19. J Enzyme Inhib Med Chem. 2021;36:1258–1267. doi:10.1080/14756366.2021.1937144
   PubMed Web of Science ®Google Scholar
• He Z, Liu JJ, Ma SL. Analysis of mitochondrial function in lymphocytes obtained from COVID-19 patients. Int J Immun Pharm. 2023;37:3946320231210736. doi:10.1177/03946320231210736
   Google Scholar
• Prikazchikov SV, Generalov VO, Sadykov TR, et al. Neurological complications of Covid-19: Review of literature and own experience. Probl Sotsialnoi Gig Zdravookhranenniiai Istor Med. 2021;29:1304–1310. doi:10.32687/0869-866X-2021-29-s2-1304-1310
   PubMedGoogle Scholar
• Clutton G, Mollan K, Hudgens M, et al. A reproducible, objective method using mitoTracker(R) fluorescent dyes to assess mitochondrial mass in T cells by flow cytometry. Cytometry A. 2019;95:450–456. doi:10.1002/cyto.a.23705
   PubMedGoogle Scholar
• Pang LX, Cai WW, Chen L, et al. The diagnostic value of mitochondrial mass of peripheral T lymphocytes in early sepsis. Front Public Health. 2022;10:928306. doi:10.3389/fpubh.2022.928306
   PubMed Web of Science ®Google Scholar
• Chen YY, Shen X, Wang YJ, et al. Evaluation of the cycle threshold values of RT-PCR for SARS-CoV-2 in COVID-19 patients in predicting epidemic dynamics and monitoring surface contamination. J Infect Public Health. 2022;15:1494–1496. doi:10.1016/j.jiph.2022.11.012
   PubMed Web of Science ®Google Scholar
• Taquet M, Luciano S, Geddes JR, et al. Bidirectional associations between COVID-19 and psychiatric disorder: retrospective cohort studies of 62 354 COVID-19 cases in the USA. Lancet Psychiatry. 2021;8:130–140. doi:10.1016/S2215-0366(20)30462-4
   PubMed Web of Science ®Google Scholar
• Fonseca L, Diniz E, Mendonça G, et al. Schizophrenia and COVID-19: risks and recommendations. Brazilian J Psych. 2020;42:236–238. doi:10.1590/1516-4446-2020-0010
   Google Scholar
• Clark R, Waters B, Stanfill AG. Elevated liver function tests in COVID-19: causes, clinical evidence, and potential treatments. Nurse Pract. 2021;46:21–26. doi:10.1097/01.NPR.0000722316.63824.f9
   PubMed Web of Science ®Google Scholar
• Nugent J, Aklilu A, Yamamoto Y, et al. Assessment of acute kidney injury and longitudinal kidney function after hospital discharge among patients with and without COVID-19. JAMA Network Open. 2021;4:e211095. doi:10.1093/schbul/sbaa051
   PubMed Web of Science ®Google Scholar
• Qi X, Kong H, Ding W, et al. Abnormal coagulation function of patients with COVID-19 Is significantly related to hypocalcemia and severe inflammation. Front Med Lausanne. 2021;8:638194. doi:10.3389/fmed.2021.638194
   PubMed Web of Science ®Google Scholar
• Karakas Ugurlu G, Ulusoy Kaymak S, Ugurlu M, et al. Total white blood cell count, liver enzymes, and metabolic syndrome in schizophrenia. Turk J Med Sci. 2016;46:259–264. doi:10.3906/sag-1407-60
   PubMed Web of Science ®Google Scholar
• Lin C, Hu Q, Dong J, et al. Serum metabolic signatures of schizophrenia patients complicated with hepatitis B virus infection: a (1)H NMR-based metabolomics study. Front Psychiatry. 2022;13:998709. doi:10.3389/fpsyt.2022.998709
   PubMed Web of Science ®Google Scholar
• Zhu H, Liu X, Xue Y, et al. Seroepidemiology of hepatitis B virus infection among Chinese schizophrenia patients. J Infect Dev Ctries. 2015;9:512–518. doi:10.3855/jidc.5416
   PubMed Web of Science ®Google Scholar
• Terpos E, Ntanasis-Stathopoulos I, Elalamy I, et al. Hematological findings and complications of COVID-19. Am J Hematol. 2020;95:834–847. doi:10.1002/ajh.25829
   PubMed Web of Science ®Google Scholar
• Robicsek O, Karry R, Petit I, et al. Abnormal neuronal differentiation and mitochondrial dysfunction in hair follicle-derived induced pluripotent stem cells of schizophrenia patients. Mol Psychiatry. 2013;18:1067–1076. doi:10.1038/mp.2013.67
   PubMed Web of Science ®Google Scholar
• Hu A, Li F, Guo L, et al. Mitochondrial Damage of Lymphocytes in Patients with Acute Relapse of Schizophrenia: a Correlational Study with Efficacy and Clinical Symptoms. Neuropsychiatr Dis Treat. 2022;18:2455–2466. doi:10.2147/NDT.S380353
   PubMed Web of Science ®Google Scholar
• Nagamine T. Abnormal laboratory values during the acute and recovery phases in schizophrenic patients: a retrospective study. Neuropsychiatr Dis Treat. 2010;6:281–288. doi:10.2147/ndt.s11319
   PubMed Web of Science ®Google Scholar
• Chu M, Zhao X, Tang L, et al. The correlation of lymphocytes with disease progression of COVID-19. Medicine. 2023;102:e36244. doi:10.1097/MD.0000000000036244
   PubMed Web of Science ®Google Scholar
• Saleh J, Peyssonnaux C, Singh KK, et al. Mitochondria and microbiota dysfunction in COVID-19 pathogenesis. Mitochondrion. 2020;54:1–7. doi:10.1016/j.mito.2020.06.008
   PubMed Web of Science ®Google Scholar
• Leirer DJ, Iyegbe CO, Di Forti M, et al. Differential gene expression analysis in blood of first episode psychosis patients. Schizophr Res. 2019;209:88–97. doi:10.1016/j.schres.2019.05.011
   PubMed Web of Science ®Google Scholar